![Somatics Thymatron System IV User Manual Download Page 10](http://html.mh-extra.com/html/somatics/thymatron-system-iv/thymatron-system-iv_user-manual_1317304010.webp)
Thymatron
®
System IV Instructions for Use
9
Do not dispose of your Thymatron® System IV device in the general waste. As per Directive
2002/96/EC for the disposal of electrical and electronic equipment, please contact the
manufacturer for instructions.
Prior to initiating ECT on a patient with a cochlear implant, healthcare professionals should
discuss the issue with an otolaryngologist or audiologist and review the cochlear implant
Instructions for Use.
Thymapad® electrodes are single-use only and must be discarded after the treatment. The
Thymatron® System IV Treatment Cable, Monitoring Cable and lead wires can be cleaned by
wiping them off with a Germicidal Disposable Cloth. Steel stimulus electrodes may be cleaned
with soapy water or alcohol. The Thymatron® device has no special requirements for restricted
environment during transport or storage, beyond Standard Sub-clause 10.1 criteria.
EEG, EMG and ECG are shown only to assess treatment quality and must not be used for
monitoring or diagnosis.
ADVERSE EVENTS
As with any therapy, ECT has risks. Certain patients will experience adverse events in conjunction with
electroconvulsive therapy. Patients should be made aware of these risks and confirm that they fully understand
them prior to consenting to therapy.
Per FDA requirements, the treating doctor should include in the written Informed Consent form of each ECT
patient a statement of the potential adverse effects from ECT as described in this manual.
The most common reported adverse effects of ECT are: Headache. Muscle soreness. Mild to moderate
pain/discomfort, including jaw pain. Nausea. Disorientation immediately after seizure induction. Memory
dysfunction (see further discussion below).
CAUTION
CAUTION
CAUTION
CAUTION